Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003073021 | SCV003472250 | likely benign | not provided | 2025-01-21 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005028209 | SCV005653956 | uncertain significance | Autosomal recessive Alport syndrome; Hematuria, benign familial, 1 | 2024-04-23 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004529202 | SCV004109154 | uncertain significance | COL4A4-related disorder | 2024-05-30 | no assertion criteria provided | clinical testing | The COL4A4 c.2722C>T variant is predicted to result in the amino acid substitution p.Arg908Trp. This variant has been reported as a variant of uncertain significance in a daughter with hematuria, but was not detected in the similarly affected father (Slajpah et al. 2007. PubMed ID: 17396119). This variant is reported in 0.038% of alleles in individuals of Latino descent in gnomAD. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |